ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,606Medicare Part D Prescriptions Filled, Including Refills

Rank: 51 out of 1155

$445K Total Retail Price of All Prescriptions

Rank: 72 out of 1155

483 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
23% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 483 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

11% of this provider’s 483 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 8,366 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
AMLODIPINE BESYLATE 532 478 1 6
SIMVASTATIN 319 317 2 3
LEVOTHYROXINE SODIUM 308 260 3 2
OMEPRAZOLE 275 197 4 5
METOPROLOL SUCCINATE 256 230 5 17
GABAPENTIN 239 191 6 15
ATENOLOL 234 216 7 10
BENAZEPRIL HCL 217 182 8 85
LISINOPRIL 211 206 9 1
ATORVASTATIN CALCIUM 209 177 10 12
DOXAZOSIN MESYLATE 206 174 11 56
HYDROCHLOROTHIAZIDE 192 164 12 9
FUROSEMIDE 191 170 13 8
ALLOPURINOL 146 132 14 29
PRAVASTATIN SODIUM 140 120 15 20
TAMSULOSIN HCL 127 111 16 27
CITALOPRAM HBR 125 119 17 19
LOSARTAN POTASSIUM 124 106 18 18
HYDROCODONE-ACETAMINOPHEN 123 97 S3 19 4
METFORMIN HCL ER 123 113 19 53
CARVEDILOL 109 97 21 28
GLIMEPIRIDE 108 105 22 43
PANTOPRAZOLE SODIUM 106 106 23 47
METOPROLOL TARTRATE 100 95 24 14
DIOVAN 94 94 25 74
LOVASTATIN 93 93 26 13
LIOTHYRONINE SODIUM 92 63 27 137
VERAPAMIL ER 91 81 28 114
RANITIDINE HCL 88 88 29 33
POTASSIUM CHLORIDE 86 68 30 16
FLUTICASONE PROPIONATE 85 74 31 37
ROPINIROLE HCL 85 76 31 94
TRAMADOL HCL 85 65 31 32
LISINOPRIL-HYDROCHLOROTHIAZIDE 83 69 34 26
LOSARTAN-HYDROCHLOROTHIAZIDE 78 62 35 65
LANTUS 73 56 36 39
NIASPAN 70 68 37 168
FLOVENT HFA 69 53 38 158
METFORMIN HCL 63 50 39 7
ALENDRONATE SODIUM 60 48 40 25
NAMENDA 57 57 41 67
AMITRIPTYLINE HCL 56 46 R 42 42
DONEPEZIL HCL 56 55 42 41
METOCLOPRAMIDE HCL 55 38 44 152
PREDNISONE 55 43 44 40
CYCLOBENZAPRINE HCL 53 32 R 46 38
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 24, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.